Results for tag: "AR101"

The AR101 market is a subset of the larger allergy drug market, which is composed of medications used to treat allergic reactions. AR101 is a specific type of allergy drug, an oral immunotherapy, which is designed to desensitize patients to allergens. It works by introducing small amounts of the allergen into the patient's body over time, allowing them to build up a tolerance. AR101 is typically used to treat allergies to peanuts, tree nuts, and other food allergens. The AR101 market is relatively new, but is growing rapidly as more people become aware of the potential benefits of this type of therapy. It is expected to continue to grow as more research is conducted and more treatments become available. Some companies in the AR101 market include Aimmune Therapeutics, DBV Technologies, and Allergen Research Corporation. Show Less Read more